Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
19,816,887
-
Share change
-
+685,615
-
Total reported value
-
$198,166,730
-
Price per share
-
$10.00
-
Number of holders
-
45
-
Value change
-
+$71,378
-
Number of buys
-
23
-
Number of sells
-
17
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q3 2018
As of 30 Sep 2018,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,816,887 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, ArrowMark Colorado Holdings LLC, BlackRock Inc., Rock Springs Capital Management LP, ProQuest Associates IV LLC, RHO CAPITAL PARTNERS INC, Vanguard Group Inc, EcoR1 Capital, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.